Aurinia Pharmaceuticals (AUPH) PT Lowered to $31 at RBC Capital

February 23, 2022 6:23 AM EST Send to a Friend

RBC Capital analyst Douglas Miehm ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Aurinia Pharmaceuticals (AUPH) PT Lowered to $31 at RBC Capital

Member Login

Free News Feed